Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study
复制标题
DOI：
10.1136/svn-2020-000431
复制
发表时间：
2020-09-01
影响因子：
5.9
通讯作者：
Hu, Bo
中科院分区：
文献类型：
--
作者：
Li, Yanan;Li, Man;Hu, Bo
背景与目的COVID-19是由严重急性呼吸道综合征冠状病毒2型（SARS-CoV-2）引起的传染病。除呼吸系统并发症外，在部分COVID-19患者中观察到急性脑血管病（CVD）。因此，我们描述了SARS-CoV-2感染并发CVD的临床特征、实验室特征、治疗和结局。材料与方法收集并分析人口学和临床特征、实验室检查结果、治疗和临床结局。比较了有或没有新发CVD的COVID-19患者的临床特征和实验室检查结果。结果219例COVID-19患者中，10例（4.6%）发生急性缺血性卒中，1例（0.5%）发生脑出血。COVID-19新发CVD的年龄明显更大（75.7 +/- 10.8岁vs 52.1 +/- 15.3岁，p
Background and purpose COVID-19 is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Apart from respiratory complications, acute cerebrovascular disease (CVD) has been observed in some patients with COVID-19. Therefore, we described the clinical characteristics, laboratory features, treatment and outcomes of CVD complicating SARS-CoV-2 infection. Materials and methods Demographic and clinical characteristics, laboratory findings, treatments and clinical outcomes were collected and analysed. Clinical characteristics and laboratory findings of patients with COVID-19 with or without new-onset CVD were compared. Results Of 219 patients with COVID-19, 10 (4.6%) developed acute ischaemic stroke and 1 (0.5%) had intracerebral haemorrhage. COVID-19 with new onset of CVD were significantly older (75.7 +/- 10.8 years vs 52.1 +/- 15.3 years, p